In the original article, there was a mistake in [Table 1](#T1){ref-type="table"} as published. The structure of SPR206 was partially incorrect. In the correct structure, R(FA) is (3*S*)-4-amino-3-(3-chlorophenyl)butanoyl, R1 is absent, and R3 is Dap^+^. The corrected [Table 1](#T1){ref-type="table"} appears below.

###### 

The structures of polymyxin B, colistin, and the novel polymyxin derivatives that display improved efficacy in animal infection models (compounds 4-10)[^a^](#TN1){ref-type="table-fn"},[^b^](#TN2){ref-type="table-fn"}.

       **Compound**             **R (FA)**                                            **R1**    **R2**   **R3**    **R4**     **R5**    **R6**   **R7**   **R8**    **R9**    **R10**
  ---- ------------------------ ----------------------------------------------------- --------- -------- --------- ---------- --------- -------- -------- --------- --------- ---------
  1    Polymyxin B (PMB)        Methyloctanoyl/methylheptanoyl                        -Dab^+^   -Thr     -Dab^+^   -cy\[Dab   -Dab^+^   -DPhe    -Leu     -Dab^+^   -Dab^+^   -Thr\]
  2    Colistin (polymyxin E)   Methyloctanoyl/methylheptanoyl                        -Dab^+^   -Thr     -Dab^+^   -cy\[Dab   -Dab^+^   -DLeu    -Leu     -Dab^+^   -Dab^+^   -Thr\]
  3    CB-182,804               2-chloro-phenylamino-carbonyl                         -Dab^+^   -Thr     -Dab^+^   -cy\[Dab   -Dab^+^   -DPhe    -Leu     -Dab^+^   -Dab^+^   -Thr\]
  4    FADDI-002                Octanoyl                                              -Dab^+^   -Thr     -Dab^+^   -cy\[Dab   -Dab^+^   -DPhe    -Ada     -Dab^+^   -Dab^+^   -Thr\]
  5    FADDI-287                Octanoyl                                              -Dab^+^   -Thr     -Dap^+^   -cy\[Dab   -Dab^+^   -DLeu    -Abu     -Dab^+^   -Dab^+^   -Thr\]
  6    CA824                    (S)-1-(2-methylpropyl)-piperazine-2-carbonyl^+^       --        -Thr     -Dab^+^   -cy\[Dab   -Dab^+^   -DPhe    -Leu     -Dab^+^   -Dab^+^   -Thr\]
  7    SPR206                   (3*S*)-4-amino-3-(3-chlorophenyl)butanoyl             --        -Thr     -Dap^+^   -cy\[Dab   -Dab^+^   -DPhe    -Leu     -Dab^+^   -Dab^+^   -Thr\]
  8    MicuRx-12                3-(2,2-dimethyl-butanoyloxy)-propanoyl (ester bond)   -Dab^+^   -Thr     -Dab^+^   -cy\[Dab   -Dab^+^   -DPhe    -Leu     -Dab^+^   -Dab^+^   -Thr\]
  9    NAB739                   Octanoyl                                              --        -Thr     -DSer     -cy\[Dab   -Dab^+^   -DPhe    -Leu     -Dab^+^   -Dab^+^   -Thr\]
  10   NAB815                   Octanoyl                                              -Dab^+^   -Thr     -DThr     -cy\[Dab   -Dab^+^   -DPhe    -Leu     -Abu      -Dab^+^   -Thr\]
  11   SPR741 (NAB741)          Acetyl                                                --        -Thr     -DSer     -cy\[Dab   -Dab^+^   -DPhe    -Leu     -Dab^+^   -Dab^+^   -Thr\]

*The structure of one discontinued derivative (compound 3) as well as that of the potentiator compound SPR741 (NAB741) are also shown*.

*Amino acyl residues that differ from those in polymyxin B are boxed*.

*Abu, aminobutyryl; Ada, aminodecanoyl; Dap, diaminopropionyl; cy, cyclic portion indicated with brackets; Dab, diaminobutyryl; FA, fatty acyl*.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
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